Drug shortage
Sertraline Hydrochloride Tablet · Strides Pharma Inc.
FDA drug shortage · To Be Discontinued · updated Jan 22, 2025
Key facts
| Generic name | Sertraline Hydrochloride Tablet |
|---|---|
| Company | Strides Pharma Inc. |
| Presentation | Sertraline Hydrochloride, Tablet, 50 mg (NDC 71093-130-03) |
| Dosage form | Tablet |
| Status | To Be Discontinued |
| Therapeutic category | Psychiatry |
| Package NDCs | 71093-130-03 |
| First posted | Jan 22, 2025 |
| Last updated | Jan 22, 2025 |
| Discontinued | Jan 22, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: